6
Oct
2026
Heraeus Preciou Metals
Exhibitor at CPHI Milan 2026 stand 2F104, API
About Us
Categories
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 2F104, API
Products Featured at CPHI Milan 2026
-
Product HPAPIs Circlear
Every second cancer therapy uses active ingredients containing platinum, resulting in an annual market demand of roughly 2 tons of platinum – a demand that is strongly increasing. If only primary materials are used to meet this demand, the platinum alone would account for more than 63,000 tons of CO2e per ... -
Product Oxaliplatin
Heraeus Precious Metals business line Pharmaceutical Ingredients provides a wide range of active pharmaceutical ingredients, which includes Oxaliplatin. Contact us for more information. -
Product Carboplatin
Heraeus Precious Metals business line Pharmaceutical Ingredients provides a wide range of active pharmaceutical ingredients, which includes Carboplatin. Contact us for more information. -
Product Cisplatin
Heraeus Precious Metals business line Pharmaceutical Ingredients provides a wide range of active pharmaceutical ingredients, which includes Cisplatin. Contact us for more information. -
Product Bendamustine hydrochloride monohydrate
Heraeus Precious Metals business line Pharmaceutical Ingredients provides a wide range of active pharmaceutical ingredients, which includes Bendamustine hydrochloride monohydrate. Contact us for more information.
Heraeus Precious Metals GmbH & Co. KG Resources (1)
-
Brochure Precious Ingredients for Precious Lives - Your specialist for highly-potent anti-cancer APIs
Heraeus Precious Metals specializes in manufacturing of generic highly potent active pharmaceutical ingredients (HPAPIs) with a focus on platinum-based HPAPIs for cancer treatment. We have been US-FDA-approved for over 35 years, maintaining an exceptional track record with major health agencies worldwide. Our commitment to excellence has secured us a prominent global position in the supply of high-quality HPAPIs, reflecting our dedication to improving patient outcomes.




